arrow
S

Shao-Lai Zhou

复旦大学
H指数:34
被引数:5,357

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial

围手术期卡瑞利珠单抗联合瑞戈非尼 versus 手术单药治疗复发风险为中高危的可切除肝细胞癌患者(CARES-009):一项随机II/III期试验

2025-10-190
PRE
Corrigendum to “CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling” [Cancer Lett. 358 2015 Pages 124–135]

勘误:“CXCR2/CXCL5轴通过激活PI3K/Akt/GSK-3β/Snail信号通路促进肝癌细胞的上皮-间质转化” [Cancer Lett. 358 2015 第124-135页]

2025-07-280
PRE
MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis (vol 15 , 828 , 2024)

MicroRNA-29a诱导5-羟甲基胞嘧啶的丢失,并通过TET-SOCS1-MMP9信号轴促进肝细胞癌的转移 (第15卷,828,2024)

2024-11-140
OAAI
An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression
2023-06-1959
OAAI
Reply
2022-03-300
PRE